AU2001295885A1 - Cosmetic formulation - Google Patents
Cosmetic formulationInfo
- Publication number
- AU2001295885A1 AU2001295885A1 AU2001295885A AU9588501A AU2001295885A1 AU 2001295885 A1 AU2001295885 A1 AU 2001295885A1 AU 2001295885 A AU2001295885 A AU 2001295885A AU 9588501 A AU9588501 A AU 9588501A AU 2001295885 A1 AU2001295885 A1 AU 2001295885A1
- Authority
- AU
- Australia
- Prior art keywords
- sebum
- active principles
- skin
- total weight
- topical use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims description 35
- 238000009472 formulation Methods 0.000 title claims description 20
- 239000002537 cosmetic Substances 0.000 title claims description 11
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 claims description 20
- 210000002374 sebum Anatomy 0.000 claims description 18
- 239000006071 cream Substances 0.000 claims description 15
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 11
- 235000019198 oils Nutrition 0.000 claims description 11
- 230000000699 topical effect Effects 0.000 claims description 11
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 10
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 10
- 229960002389 glycol salicylate Drugs 0.000 claims description 10
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims description 10
- 229940035936 ubiquinone Drugs 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 235000006708 antioxidants Nutrition 0.000 claims description 9
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 8
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 8
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 8
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 7
- 244000042664 Matricaria chamomilla Species 0.000 claims description 7
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 229940042585 tocopherol acetate Drugs 0.000 claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 5
- 230000003796 beauty Effects 0.000 claims description 5
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 claims description 5
- 239000000626 magnesium lactate Substances 0.000 claims description 5
- 229960004658 magnesium lactate Drugs 0.000 claims description 5
- 235000015229 magnesium lactate Nutrition 0.000 claims description 5
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 4
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 4
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 4
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 229960003720 enoxolone Drugs 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229960001340 histamine Drugs 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 229960001173 oxybenzone Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 238000006114 decarboxylation reaction Methods 0.000 claims description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000005493 rutin Nutrition 0.000 claims description 3
- 229960004555 rutoside Drugs 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 241000218790 Ginkgoales Species 0.000 claims description 2
- 235000019493 Macadamia oil Nutrition 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- 229940119170 jojoba wax Drugs 0.000 claims description 2
- 239000010469 macadamia oil Substances 0.000 claims description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000011252 protective cream Substances 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 240000006432 Carica papaya Species 0.000 description 4
- 235000009467 Carica papaya Nutrition 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Description
Cosmetic formulation
The present invention relates to cosmetics and more particularly cosmetic formulations for topical administering to protect skin against exogenous or endogenous harmful agents as well as to balance again the dermal homeostasis lipids altered by dermatosis and ageing. Such formulations include active principles of strictly natural origin, all of them fulfilling the following requirements: a) having a lipid composition which is close to the human sebum; b) having a pool of antioxidants similar to those present in sebum and skin; c) having anti-inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed.
The rational principle of the present invention is to formulate and to prepare topical products of strictly natural origin which are capable of reproducing the human sebum so as to carry the active principles contained therein without the skin gives rise to self- defence systems against exogenous products by the contact with the carrier.
Another object of the invention is to provide anallergenic cosmetic formulations which are unable to induce dermal allergic contact reactions.
In order to achieve such result, according to the invention, it is necessary to provide formulations containing active principles of strictly natural
origin which fulfil three .main requirements: a) having a lipid composition which is as close as possible to the human sebum; b) having a pool of antioxidants similar to those present in sebum and skin; c) having anti- inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed. The whole knowledge about chemistry and biology of dermal lipids brought to formulate a mixture of lipids similar to sebum of strictly natural origin in a previous Patent application of the same Applicant which is integral with the present description. Such formulation is close to the lipid composition of human sebum produced by oil glands.
A preferred formulation of such mixture (which will be referred to thereafter as oil A*) is as follows:
% Macadamia oil 50 Jojoba oil (wax) 24.5
Avocado oil 10
Unsaponifiable olive oil (squalene) 12 Free cholesterol 1.5
Oily cholesterol 0.5 Soya phospholipids 1.4
BHT (butylhydroxytoluene) 0.1
Therefore, a preparation having such formulation can provide a lipid component which is quite similar to the component present in the human sebum both from the quantitative and qualitative points of view according to above item a) . As far as item b) is concerned, i.e. the presence of
antioxidants similar to those contained in human sebum and skin, the inventor has found recently, according to the researches carried out, that human sebum contains two main antioxidants, i.e. vitamin E (d-RRR- α-tocopherol) and ubiquinone (CoQ10) , which operate in syntony and synergy to protect sebum and particularly the polyunsaturated hydrocarbon squalene from the oxidation induced by solar radiations and other oxidizing agents present in the environment. Therefore, vitamin E (0.5-1.5%) and ubiquinone (0.02- 0.2%) together with magnesium ascorbyl phosphate or ascorbyl dipalmitate, a steady form of vitamin C (1- 3%) the hydrolysis of which generates vitamin C, can be used as main natural physiological antioxidants in the formulations according to the present invention. In some cases, extremely active flavonoids such as rutin and those present in association with ginkgoales in ginkgo biloba can also be used. The further characterizing component of the formulations of the present patent application is the presence of anti-inflammatory and anti-free-radical agents as well as inhibitors of the histidine decarboxylatio . It is known that histamine is formed from the decarboxylation of histidine, a molecule directly involved in the allergic reactions.
The invention proposes magnesium lactate (0.2-0.8%) and glycol salicylate (0.5-2.0%) to be used as inhibitors' of the histidine decarboxylation. Glycol salicylate is also known in the literature as dermal "counterirritant and anti-inflammatory" .
The antihistaminic action of such molecules was proved experimentally to be synergical with the above- mentioned antioxidants and anti-inflammatory agents such as α-bisabolol (0.2-0.8%) incorporated in its
natural matrix, i.e. the extract of chamomile (0.1- 0.3%), glycyrrhetinic acid or its esters (0.2-1.0%), rutin (0.05-0.3%), the extract of ginkgo biloba (0.05- 0.3%), and aloe gel (0.1-0.6%) which is rich in polysaccharides .
A further characteristic of the invention is to provide in some case the use of benzophenone-3 , a known solar filter, whose anti-UV-A and anti-UV-B activity is associated with the anti-UV-B activity of glycol salicylate.
According to such teachings, some preferred formulations of nutrient anti-wrinkle oils and creams, beauty creams, anti-cellulitis creams, and cleansing milks within the scope of the present invention will be given herebelow only by way of a not limiting example .
Both the preferred proportion and the proportion range allowing the purposes of the present invention to be reached are mentioned for each component in the formulations of the following examples.
EXAMPLE 1 NUTRIENT ANTI-WRINKLE OILS
Ingredients (g, ml) range %
ACTIVE PRINCIPLES Sebum-similar oil (A*) 95 93-97 Ubiquinone 0.1 0.02-0.2
Natural vitamin E acetate 1.0 0.5-2.0 Ascorbyl palmitate 0.2 α-Bisabolol 0.2 0.1-0.5 Oily extract of chamomile 0.9 0.5-3 EXCIPIENT Soya phospholipids 2.3 1.5-4 Sepicide HB 0.4 0.4 SCENT Light perfume or others 0.1 0.05-0.3
EXAMPLE 2 NATURAL NUTRIENT SEBUM-SIMILAR CREAM
Ingredients (g, ml) % range
ACTIVE PRINCIPLES Sebum-similar oil (A*) 35 30-40
Ubiquinone 0.1 0.02-0.2
Natural vitamin E acetate 1.0 0.5-1.5
Glycol salicylate 1.0 0.5-1.5 α-Bisabolol 0.3 0.2-0.6 Extract of chamomile 0.1 0.1-0.3
Glycyrrhetinic acid or its esters 0.4 0.2-1
EXCIPIENT
Soya phospholipids 2.0 1.0-4
Glycerol 2.0 1.0-4 BHT (butylhydroxytoluene) 0.1
Tegin M (glycerol monostearate) 2.5
Tegocare 150 10.0*
Sepicide HB 0.4
Imidazolynidyl urea (IMU) 0.2 Bisodium EDTA 0.1
Water q.s. to 100
Scent 0.1 0.05-0.3
It should be noted that Tegin M, Tegocare 150 and
Sepicide HB can be replaced with Microcombin (0.5%), Tegin M (3.8%), Brij 721 (2.0%), Brij 58 (3.0%), and stearic alcohol (2.5%).
EXAMPLE 3 IMMUGEN CREAM
Ingredients (g, ml) % ranσe % ACTIVE PRINCIPLES
Sebum-similar oil (A*) 10 6-12
Ubiquinone 0.05 0.05-0.15
Vitamin E acetate 1.0 0.5-1.5
Ascorbyl palmitate 1.5 1-3 α-Bisabolol 0.3 0.2-0.5
Extract of chamomile 0.1 0..1-0.3
Glycol salicylate 1.0 0. .5-2
Magnesium lactate 0.3 0. .2-0.4
1-metionine 0.02 0. .01-0.03 Benzophenone-3 2.0 1- -3
EXCIPIENT
Silicone oil 350 1.0
Stearyl alcohol 1.0
Xanthan gum 0.2 Simulsol 165 V 1.0
BHT 0.1
Bisodium EDTA 0.2
Sepicide HB 0.4
Imidazolynidyl urea (IMU) 0.2 Brij 721 2.0
Brij 72 3.0
Water q.s. to 100
Scent 0.05 0 .005-0.3
Carbopol (0.3-0.4%) neutralized with NaOH (0.13-0.15%) can also be used as thickener. In any case, the excipients may vary. pH 6 : adjusting with EDTA or lactic acid
Papaya extract 1-2%
(for foreign creams)
BEAUTY CREAMS EXAMPLE 4 EXAMPLE 5 EXAMPLE 6
Carbopol (0.3*0.4%) neutralized with NaOH (0.13*0.15% can also be used as thickener. In any case the excipients may vary. pH 6: adjusting with EDTA or lactic acid. (*) Papaya extract (for foreign creams) 1-2%
CLEANSING MILK
Sodium carbonate or NaOH to increase pH to 6 Papaya extract (for foreign creams)
MOISTURIZING CREAM
Carbopol (0.3*0.4%) neutralized with NaOH (0.13-^0.15%) can also be used as thickener. In any case the excipients may vary. pH 6: adjusting with EDTA or lactic acid.
Papaya extract (for foreign creams) 1-2%
It is self-evident from the examples disclosed above that a number of modi ications and changes may be made to the formulations as far as the active principles is concerned without departing from the scope of the invention. Therefore, such modifications and changes, including the variations of nature and composition of the excipients, fall within the scope of the following claims which are intended to cover the general, specific features of the invention.
Claims (14)
1. A cosmetic formulation for topical use, including a mixture of active principles of natural origin fulfilling the following requirements: having a lipid composition close to the human sebum; having a pool of antioxidants similar to those present in sebum and skin; having anti-inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed.
2. The cosmetic formulation of claim 1, including: a mixture of macadamia oil and avocado oil in the same proportion as triglycerides in sebum; unsaponifiable olive oil in a proportion corresponding to squalene in sebum; jojoba wax in a proportion corresponding to waxes in sebum; free, esterified cholesterol in the same quantities as those in human sebum; a quantity of vitamin E (s-RRR-α-tocopherol) and ubiquinone as physiological antioxidants to protect sebum from oxidation induced by solar radiation and other oxidizing agents in the environment; an effective quantity of magnesium lactate and glycol salicylate as inhibitor of the histidine decarboxylation.
3. The cosmetic formulation of the preceding claims, characterized in that vitamin E and ubiquinone are used in association with effective quantities of ascorbyl dipalmitate, a steady form of vitamin C, or magnesium ascorbyl phosphate.
4. The cosmetic formulation of the preceding claims, further including an effective quantity of active flavonoids such as rutin and ginkgoales of ginkgo biloba as antioxidants.
5. The cosmetic formulation of the preceding claims, further including an effective quantity of α-bisabolol in its natural matrix and glycyrrhetinic acid or its esters to provide a synergic antihistaminic effect of magnesium lactate and glycol salicylate.
6. The cosmetic formulation of the preceding claims, further including benzophenone-3, whose anti-UV-A and anti-UV-B activity is associated with the anti-UV-B activity of glycol salicylate.
7. A nutrient, anti-wrinkle oil for topical use on skin, including the following active principles in weight percentages of the total weight of the product : Sebum-similar oil (A*) of the known type 93-97% Ubiquinone 0.02-0.2%
Natural vitamin E acetate 0.5-2.0%
Ascorbyl palmitate about 0.2% α-Bisabolol 0.1-0.5%
Oily extract of chamomile 0.5-3%
8. A natural nutrient, sebum-similar cream for topical use on skin, including the following active principles in weight percentages of the total weight of the product : Sebum-similar oil (A*) of the known type 30-40%
Ubiquinone 0.02-0.2%
Natural vitamin E acetate 0.5-1.5%
Glycol salicylate 0.5-1,5% α-Bisabolol 0.2-0.6% Extract of chamomile 0.1-0.3% Glycyrrhetinic acid or its esters 0.2-1%
9. A protective cream for topical use on skin, including the following active principles in weight percentages of the total weight of the composition: Sebum-similar oil (A*) of the known type 6-12
Ubiquinone 0.05-0.15
Vitamin E acetate 0.5-1.5
Ascorbyl palmitate 1-3
Glycol salicylate 0.5-2
Magnesium lactate 0.2-0.4 α-Bisabolol 0.2-0.5
Extract of chamomile 0.1-0.3
1-metionine 0.01-0.03
Benzophenone-3 1-3
10. Nutrient beauty cream for topical use on young skins, including the following active principles in weight percentage of the total weight of the composition:
11. A beauty cream for topical use for the prevention of skin ageing, including the following active principles in weight percentage of the total weight of the composition:
12. An anti-wrinkle beauty cream for the topical treatment of the skin ageing, including the following active principles in weight percentage of the total weight of the composition:
13. A cleansing milk for topical use on skin, including the following active principles in weight percentage of the total weight of the composition:
14. A hydrating milk for topical use on skin, including the following active principles in weight percentage of the total weight of the composition:
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2000A000520 | 2000-09-28 | ||
| IT2000RM000520A IT1317911B1 (en) | 2000-09-28 | 2000-09-28 | COSMETIC FORMULATION. |
| PCT/IT2001/000495 WO2002026207A2 (en) | 2000-09-28 | 2001-09-27 | Cosmetic formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001295885A1 true AU2001295885A1 (en) | 2002-04-08 |
Family
ID=11454933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001295885A Abandoned AU2001295885A1 (en) | 2000-09-28 | 2001-09-27 | Cosmetic formulation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040013618A1 (en) |
| EP (1) | EP1322285A2 (en) |
| JP (1) | JP2004509913A (en) |
| AU (1) | AU2001295885A1 (en) |
| CA (1) | CA2423713A1 (en) |
| IT (1) | IT1317911B1 (en) |
| WO (1) | WO2002026207A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119663925A (en) * | 2024-11-28 | 2025-03-21 | 中交广州航道局有限公司 | Sand taking rake head with coral reef stone breaking device |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2831442B1 (en) * | 2001-10-30 | 2005-02-11 | Oreal | COSMETIC COMPOSITION MIMING THE SEBUM, AND USES THEREOF |
| JP2004075549A (en) * | 2002-08-12 | 2004-03-11 | Kanebo Ltd | Cosmetic |
| JP2004224742A (en) * | 2003-01-23 | 2004-08-12 | Umeken:Kk | Skin care preparation |
| ITRM20030204A1 (en) * | 2003-04-29 | 2004-10-30 | Provincia Italiana Della Congregazi One Dei Figli | DERMATOLOGICAL FORMULATION. |
| JP2005053842A (en) * | 2003-08-05 | 2005-03-03 | Asahi Kasei Chemicals Corp | Skin cosmetics |
| US7416756B2 (en) | 2003-09-10 | 2008-08-26 | Eastman Chemical Company | Process for the recovery of a phytolipid composition |
| DE102004008440A1 (en) * | 2004-02-19 | 2005-09-22 | Stockhausen Gmbh | Cosmetic and / or dermatological agent for increasing the endogenous lipid content of the skin |
| JP2006056804A (en) * | 2004-08-18 | 2006-03-02 | Kanae Technos:Kk | Sheet for face pack |
| EP1827111A4 (en) * | 2004-12-22 | 2015-07-22 | Avon Prod Inc | Method and composition for reducing the appearance of wrinkles |
| US7932417B2 (en) | 2006-05-19 | 2011-04-26 | Mary Kay Inc. | Glyceryl and glycol acid compounds |
| ITRM20060557A1 (en) * | 2006-10-16 | 2008-04-17 | Opocrin Spa | PREPARATION FOR PALPEBRYAL AND PERIOCULAR HYGIENE WITH HIGH EYE AND SKIN TOLERABILITY |
| KR100823533B1 (en) * | 2007-02-27 | 2008-04-30 | 바이오스펙트럼 주식회사 | Skin condition improvement composition containing alpha bisabolol as an active ingredient |
| JP5279539B2 (en) * | 2009-02-06 | 2013-09-04 | 公益社団法人日本アロマ環境協会 | Collagen production promoter, cosmetics, collagen production promotion method |
| FR2949044B1 (en) | 2009-08-12 | 2021-05-07 | Expanscience Lab | COMPOSITION INCLUDING A FRACTION OF THE UNSAPONIFIABLE |
| US8343468B2 (en) * | 2009-10-26 | 2013-01-01 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
| JP2012158554A (en) * | 2011-02-01 | 2012-08-23 | Mikimoto Pharmaceut Co Ltd | Skin care preparation |
| ITMI20110507A1 (en) * | 2011-03-29 | 2012-09-30 | Biophil Italia Spa | COMPOSITION FOR COSMETIC USE BASED ON TRIGLYCERIDES OF VEGETABLE ORIGIN |
| DE102011087320A1 (en) * | 2011-11-29 | 2013-05-29 | Henkel Ag & Co. Kgaa | Novel combination of active ingredients for efficient anti-wrinkle action |
| WO2014041528A2 (en) * | 2012-09-14 | 2014-03-20 | Martin Roslain Margaret | A composition |
| WO2014134413A2 (en) * | 2013-03-01 | 2014-09-04 | Revlon Consumer Products Corporation | Cyrrhetinic alkyl esters and protected derivatives thereof |
| CA2905121C (en) | 2013-03-12 | 2021-10-26 | Mary Kay Inc. | Preservative system |
| EP3052603B2 (en) * | 2013-09-30 | 2023-08-09 | AAK AB (publ) | Enrichment of triterpene esters |
| EP3082758A4 (en) * | 2013-12-18 | 2017-08-23 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
| WO2017214497A1 (en) | 2016-06-10 | 2017-12-14 | Clarity Cosmetics Inc. | Non-comedogenic hair and scalp care formulations and method for use |
| JP6572337B2 (en) * | 2018-02-28 | 2019-09-04 | 株式会社ファンケル | Composition for promoting myokine production |
| US11446338B2 (en) * | 2018-05-04 | 2022-09-20 | Boris Farber | Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect |
| KR20220148853A (en) | 2020-02-28 | 2022-11-07 | 조이스 에이치. 마 | Formulations and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4022644A1 (en) * | 1990-07-17 | 1992-01-23 | Beiersdorf Ag | SKIN CARE COMBINATIONS |
| US5215759A (en) * | 1991-10-01 | 1993-06-01 | Chanel, Inc. | Cosmetic composition |
| US5494657A (en) * | 1992-04-30 | 1996-02-27 | Swenson; Russell H. | Skin care formulation |
| GB9214634D0 (en) * | 1992-07-09 | 1992-08-19 | Lalvani Kartar S | A cosmetic or pharmaceutical preparation |
| ES2173131T3 (en) * | 1995-02-02 | 2002-10-16 | Nestle Sa | MIXING OILS FOR COSMETIC PRODUCTS. |
| DE19713092A1 (en) * | 1997-03-27 | 1998-10-01 | Wacker Chemie Gmbh | Complexes of gamma-cyclodextrin and retinol or retinol derivatives, as well as processes for their preparation and their use |
| DE69710442T2 (en) * | 1997-05-02 | 2002-10-02 | Takasago International Corp., Tokio/Tokyo | Lipid composition containing liquid crystal phase |
-
2000
- 2000-09-28 IT IT2000RM000520A patent/IT1317911B1/en active
-
2001
- 2001-09-27 WO PCT/IT2001/000495 patent/WO2002026207A2/en not_active Ceased
- 2001-09-27 CA CA002423713A patent/CA2423713A1/en not_active Abandoned
- 2001-09-27 US US10/381,413 patent/US20040013618A1/en not_active Abandoned
- 2001-09-27 JP JP2002530037A patent/JP2004509913A/en active Pending
- 2001-09-27 EP EP01976625A patent/EP1322285A2/en not_active Withdrawn
- 2001-09-27 AU AU2001295885A patent/AU2001295885A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119663925A (en) * | 2024-11-28 | 2025-03-21 | 中交广州航道局有限公司 | Sand taking rake head with coral reef stone breaking device |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002026207A3 (en) | 2002-09-19 |
| IT1317911B1 (en) | 2003-07-15 |
| US20040013618A1 (en) | 2004-01-22 |
| CA2423713A1 (en) | 2002-04-04 |
| ITRM20000520A0 (en) | 2000-09-28 |
| WO2002026207A2 (en) | 2002-04-04 |
| ITRM20000520A1 (en) | 2002-03-28 |
| JP2004509913A (en) | 2004-04-02 |
| EP1322285A2 (en) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001295885A1 (en) | Cosmetic formulation | |
| EP1002526B1 (en) | Skin whitening composition containing bearberry extract and a reducing agent | |
| US5436230A (en) | Use of a growth factor in a slimming composition | |
| TW568789B (en) | Compositions containing hydroxy acids or retinoids | |
| US20130195925A1 (en) | Anti aging application and method for treating aging | |
| WO1998044904A1 (en) | Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein | |
| CA2408575A1 (en) | Cosmetic and/or dermatological composition based on cocoa extracts | |
| EP0970691B1 (en) | Composition for topical application containing a lipase, vitamin precursor and a fatty alcohol | |
| JP2552297B2 (en) | Beautiful skin cosmetics | |
| FR2687913A1 (en) | COMPOSITION FOR TOPICAL TREATMENT CONTAINING LIPID VESICLES ENCAPSULATING AT LEAST MINERAL WATER. | |
| JP6175280B2 (en) | Composition for improving pores | |
| CA2357961A1 (en) | Method for reduction of inflammation and erythema | |
| JP2003306419A (en) | Cosmetic | |
| JP2552298B2 (en) | Beautiful skin cosmetics | |
| JP2009269851A (en) | Inhibitor of prostaglandin e2 production and its utilization | |
| JP3434911B2 (en) | External preparation for skin | |
| RU2259814C2 (en) | Skin cream | |
| JPH0118044B2 (en) | ||
| JPH11322628A (en) | External preparation for skin | |
| JPH0655664B2 (en) | Beautiful skin cosmetics | |
| US20220096353A1 (en) | Reduced-cost cosmetic formulations that reduce visible signs of ageing | |
| JP2000143485A (en) | Composition for controlling aging of dermal cell | |
| JPH111422A (en) | Cosmetics | |
| RO108642B1 (en) | Day cream for oily skin | |
| JP2009137879A (en) | Skin-whitening agent and skin-whitening cosmetic containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |